Drug Trial Radar · NCT07919405
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
1,408
Planned (sponsor's estimate)
Start
Nov 11, 2026
Primary completion
Jun 1, 2028
Study completion Jul 13, 2028
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Nov 5, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is testing whether CagriSema is safe and works well in adults with high blood pressure and excess body weight. Participants will receive CagriSema, semaglutide, cagrilintide, or placebo, and treatment will be assigned by chance. CagriSema and cagrilintide are investigational medicines, while semaglutide is already available by prescription.
Conditions
- Hypertension
- Obesity
Interventions
CagriSemaDrug
CagriSema will be administered subcutaneously.
SemaglutideDrug
Semaglutide will be administered subcutaneously.
CagrilintideDrug
Cagrilintide will be administered subcutaneously.
PlaceboDrug
Placebo will be administered subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- CagriSema versus Placebo : Change in in-office systolic blood pressure (SBP)Time frame: From baseline (week 0) to week 32
Locations
212 sites in 19 countries. Site status is shown where the registry gives one.
John Muir Physicians Network
Concord, California
Aurora FDRC Inc.
Costa Mesa, California
Providence Medical Foundation
Fullerton, California
Catalina Research Institute, LLC
Montclair, California
Desert Oasis Hlthcr Med Group
Palm Springs, California
N America Res Inst - San Dimas
San Dimas, California
Chase Medical Research LLC
Waterbury, Connecticut
Clinical Res Of W Florida Inc
Clearwater, Florida
Renstar Medical Research
Ocala, Florida
Florida Institute for Clinical research
Orlando, Florida
Javara Inc. / Privia Medical Group Georgia LLC
Albany, Georgia
Hope Clin Res & Wellness
Conyers, Georgia
Endocrine Research Solutions, Inc
Roswell, Georgia
Javara Inc. / Privia Medical Group Georgia LLC
Savannah, Georgia
Great Lakes Clinical Trials
Chicago, Illinois
Koch Research
Morton, Illinois
Endeavor Health
Skokie, Illinois
Evanston Premier Hlthcr Res
Skokie, Illinois
SIU Medicine
Springfield, Illinois
Midwest Inst For Clin Res
Indianapolis, Indiana
Iowa Diabetes Research
West Des Moines, Iowa
Graves Gibert Clinic
Bowling Green, Kentucky
Monroe Biomedical Research, LLC
Louisville, Kentucky
Northern Pines Hlth Ctr, PC
Buckley, Michigan
Aa Mrc Llc
Flint, Michigan
StudyMetrix Research LLC
City of Saint Peters, Missouri
Amicis Centers of Clinical Research
St Louis, Missouri
Seacoast Kidney & Htn Specialists
Portsmouth, New Hampshire
Southgate Medical Group, LLP
West Seneca, New York
Great Lakes Medical Research
Westfield, New York
Accellacare_NC
Raleigh, North Carolina
Medication Management, LLC
Raleigh, North Carolina
Piedmont Healthcare, Inc.
Statesville, North Carolina
Diab & Endo Assoc of Stark Co
Canton, Ohio
Family Practice Center of Wadsworth Inc.
Wadsworth, Ohio
Lynn Institute of Norman
Norman, Oklahoma
Clinical Res Collaborative
Cumberland, Rhode Island
Coastal Carolina Res Ctr
North Charleston, South Carolina
Spartanburg Medical Research
Spartanburg, South Carolina
Holston Medical Group Pc
Bristol, Tennessee
Showing 40 of 212 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.